Home › Drugmaker AstraZeneca forecasts faster return to growth
 

Keywords :   


Drugmaker AstraZeneca forecasts faster return to growth

2014-01-14 17:58:07| Biotech - Topix.net

AstraZeneca expects new drugs and a recent diabetes deal to offset a wave of patent expiries and return it to growth faster than analysts predict, with 2017 revenue likely to be broadly in line with the 2013 level.

Tags: return growth faster forecasts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06VW to invest up to $5bn in Tesla rival Rivian
26.06Strategic use of soybean meal to maximize hog carcass weight during summer
26.06Eastern North Pacific Tropical Weather Outlook
26.06Atlantic Tropical Weather Outlook
26.06Aer Lingus pilots begin industrial action over pay dispute
25.06Water requirements in the summer
25.06New model Is transforming the study of liver abscesses in cattle
25.06Royal Mail buyer to make offer for all staff shares
More »